Omega-3 Fatty Acids Market Size & Share 2026-2035

Omega-3 Fatty Acids Market Trends

• Source diversification on sustained terms is a major trend that redirects dependence away from traditional marine sources and toward sustainable or alternative sources, in particular-algal-derived omega-3. DSM-Firmenich, which is the front-runner in the market, has divested all marine lipids businesses while strengthening its algal omega lifestyle. Such moves indicate the overall trend transformation in businesses.
• Algal omega-3 production provides many benefits, such as reduced pressure on wild fisheries because of controlled cultivation environments and shorter supply chains with 25-day production cycles, compared with over 24 months for fish oil. It has been found that 64% of supplement customers around the world would switch to plant-based omega-3 if it were available, mostly because of sustainability concerns and trends in plant-based diets. The intended change in preference supports the predicted CIM for algal omega-3 at 13.36% through 2030, much higher than the trend for traditional marine sources. The growth profile of the algal fraction depicts environmental awareness and technological improvements in microalgae cultivation and extraction processes.
• The evolution of markets into precision nutrition brings about the need for highly concentrated omega-3 formulations with improved bioavailability and specific therapeutic applications. More and more evidence suggests that EPA should be used by itself over the traditional combinations of EPA+DHA, and meta-analysis of 38 randomized controlled trials indicates that purified EPA gives better cardiovascular outcomes. Because of this, a scientific separation is being created between generic fish oil supplements and concentrated pharmaceutical-grade formulations.
• Omega in functional foods is among the swelling trends, as it is brought by manufacturers into various categories of foods other than the usual dietary supplements. Consumers look for convenient nutrition, hence the promising growth for functional foods that market everyday foods as nutrient delivery systems alongside supplements. That includes fortified beverages, dairy products, baked goods, and plant-based protein alternatives.

Omega-3 Fatty Acids Market Analysis

Omega-3 fatty acids market based on product type is segmented into marine-derived omega-3, algal-derived omega-3, plant-based omega-3 (ALA), prescription omega-3 drugs, concentrated & purified forms. The marine-derived omega-3 segment was valued at USD 2.3 billion in 2025, and it is anticipated to expand to 3.5% of CAGR during 2026-2035.

• Marine-derived omega-3 holds a significant share due to its rich EPA and DHA content, making it widely used across dietary supplements and functional foods. Algal-derived omega-3 is expanding steadily, supported by rising demand for vegan and sustainable alternatives, particularly in infant nutrition and fortified products. Plant-based ALA is primarily sourced from flaxseed, chia, and walnuts, serving cost-sensitive consumers, though its limited conversion into EPA and DHA restricts its functional efficiency in comparison.
• Prescription omega-3 drugs are increasingly utilized for managing cardiovascular conditions and high triglyceride levels, supported by growing clinical validation and regulated formulations. Concentrated and purified forms are gaining attention for offering higher potency, reduced impurities, and better absorption, making them suitable for premium supplements and pharmaceutical applications. This progression highlights a shift toward targeted, high-quality formulations aligned with evolving consumer and healthcare requirements.

Omega-3 fatty acids market based on application is segmented into cardiovascular health, hypertriglyceridemia treatment, general wellness & dietary supplements, functional foods & fortification, infant & maternal nutrition, and animal feed & aquaculture. The general wellness & dietary supplements segment was valued at USD 1.1 billion in 2025, and it is anticipated to expand to 3.7% of CAGR during 2026-2035.

• Cardiovascular health represents a major application area, driven by the rising prevalence of heart-related conditions and growing awareness regarding preventive healthcare. Hypertriglyceridemia treatment is gaining relevance due to increasing cases of elevated triglyceride levels and the expanding use of omega-3 in clinical interventions. General wellness & dietary supplements continue to generate strong demand as consumers increasingly focus on daily nutrition, immunity, and overall health maintenance.
• Functional foods & fortification are expanding as manufacturers incorporate omega-3 into products such as dairy, beverages, and bakery items to enhance nutritional value. Infant & maternal nutrition is growing steadily due to the importance of DHA in early cognitive and visual development. Animal feed & aquaculture also contributes significantly, with omega-3 used to improve livestock health and enhance the nutritional profile of farmed seafood.

• Pharmaceutical industry represents a critical end-user segment, driven by the increasing use of omega-3 in prescription formulations and therapeutic applications, particularly for cardiovascular and metabolic conditions. The nutraceutical & dietary supplement industry holds a prominent position due to rising consumer inclination toward preventive healthcare, daily nutrition, and natural wellness products, supported by expanding product availability and strong retail presence.
• Food & beverage industry is witnessing steady integration of omega-3 into functional and fortified products such as dairy, beverages, and bakery items, enhancing their nutritional appeal. Animal feed industry also plays a vital role, as omega-3 is incorporated to improve livestock health, productivity, and the nutritional value of animal-derived products, particularly in aquaculture and poultry sectors.

The North America omega-3 fatty acids market accounted for USD 1 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

North America holds a substantial position in the omega-3 fatty acids industry, driven by high consumer awareness, strong demand for dietary supplements, and advanced healthcare infrastructure. The United States plays a central role, supported by widespread use of omega-3 in pharmaceuticals and functional foods. Increasing adoption of preventive healthcare and premium nutritional products continues to strengthen regional demand.

The Europe omega-3 fatty acids industry accounted for USD 939 million in 2025 and is anticipated to show lucrative growth over the forecast period.

Europe demonstrates steady growth supported by strict regulatory standards and a well-established nutraceutical sector. Germany is a key contributor, with strong demand for high-quality omega-3 products in dietary supplements and functional foods. Growing preference for sustainable and plant-based sources, along with rising health consciousness among consumers, drives market expansion across the region.

Asia Pacific omega-3 fatty acids market accounted for 28% market share in 2025 and is anticipated to show lucrative growth over the forecast period.

Asia Pacific is experiencing rapid expansion due to increasing population, rising disposable income, and growing awareness of health and nutrition. China leads regional demand, supported by expanding supplement consumption and infant nutrition applications. The region also benefits from strong aquaculture activities and rising interest in fortified foods, contributing to broad market development.

Latin America omega-3 fatty acids industry is anticipated to grow at a CAGR of 3.7% during the analysis timeframe.

Latin America shows gradual growth, driven by improving healthcare awareness and expanding middle-class population. Brazil serves as a major market, with increasing demand for dietary supplements and functional foods. The region is also witnessing growth in animal feed applications, particularly in aquaculture, supporting the overall adoption of omega-3 products.

Middle East & Africa omega-3 fatty acids market is expected to grow at a CAGR of 3.8% during the analysis timeframe.

The Middle East & Africa region is developing steadily, supported by rising health awareness and increasing demand for nutritional supplements. Saudi Arabia leads market growth in the Middle East, driven by changing lifestyles and higher focus on wellness. Expanding use of omega-3 in food fortification and infant nutrition is contributing to gradual market penetration across the region.

Omega-3 Fatty Acids Market Share

• DSM-Firmenich, BASF SE, Croda International, Aker BioMarine, and Archer Daniels Midland are a significant part of the global omega-3 fatty acids industry and with further standing of being moderately consolidated with the top five players steadily holding 55% market share in the year 2025.
• The competitive landscape of the omega-3 fatty acids industry is shaped by strong focus on product quality, purity, and source diversification. Companies differentiate through sourcing strategies such as marine, algal, and plant-based inputs, addressing sustainability and dietary preferences. Technological advancements in extraction, concentration, and encapsulation enhance bioavailability and shelf stability, supporting premium product development across nutraceutical and pharmaceutical applications.
• Market competition is also influenced by regulatory compliance, supply chain management, and expanding application areas. Firms are focusing on clean-label formulations and traceability to meet evolving consumer expectations. Strategic investments in research and development, along with partnerships across value chains, enable innovation in functional foods, clinical nutrition, and fortified products, reinforcing competitive positioning in both mature and emerging markets.

Omega-3 Fatty Acids Market Companies

The major players operating in omega-3 fatty acids industry include:

• DSM-Firmenich

• BASF SE
• Croda International
• Aker BioMarine
• Archer Daniels Midland
• Cargill
• Corbion
• Omega Protein Corporation
• Epax
• KD Pharma Group
• Polaris Nutritional Lipids
• Solutex
• Veramaris
• Yield10 Bioscience
• AlgaeCytes
• Fermentalg
• Qualitas Health
• Others
• DSM-Firmenich’s models integrate proprietary technologies for cultivating microalgae with global distribution capabilities with access into segments of pharma, nutraceutical, and food production. Recent innovation includes product launch of life's OMEGA O3020, the first algal-based lipid with high EPA content available in Europe and USA, showing innovation in algal omega-3 concentration and formulation. The company has been well positioned as a sustainable brand, particularly in providing 100% vegan, algae-derived omega-3s completely independent of any fisheries-a direct response to the environmental conscience of consumers and regulatory requirements of sustainability.
• BASF SE is an integrated chemical firm with skills in omega-3 purification, concentration, and formulation technologies would manufacture pharmaceutical-grade high-concentration products. They depend on technology to devise a differentiating strategy via in-house extraction and purification techniques, achieving ultra-high concentration formulations with therapeutic applications and exceeding 85% purity. BASF allows expansion into several markets located in various countries and types of end-user applications through a global network for manufacturing and regulatory know-how.
• Croda International specializes in developing bioavailability-enhanced, high-performance omega-3 ingredients and their novel delivery systems. Besides improving omega-3 stability and absorption using expertise in surface chemistry, the company focuses on specialty applications: pharmaceutical excipients, cosmetic ingredients, and premium nutraceutical formulations. Croda's approach is more to innovate and gain a premium rather than focusing on commodity volume production.
• Aker BioMarine dominates the krill oil segment by harvesting Antarctic krill, which contain phospholipid-bound omega-3 with enhanced bioavailability and unique astaxanthin content. The company's sustainable harvesting practices and Marine Stewardship Council certification appeal to environmentally conscious consumers and premium market segments. Other strategic initiatives include entering supply agreements for pharmaceutical applications and geographic expansion through distribution partnerships.
•  Archer Daniels Midland applies agricultural processing expertise and global distribution network to omega-3 markets, emphasizing cost-effective solutions for food and feed applications. The company's strategy focuses on large-volume, commodity-grade omega-3 ingredients for functional food fortification and animal nutrition, leveraging existing customer relationships and manufacturing infrastructure.

Omega-3 Fatty Acids Industry News

• In March 2025, Innovaoleo by Natac, Natac’s omega-3 division launched Omega 3 Star. This product stands out in the market for its neutrality in terms of smell, taste, colour and provides multiple benefits for human and animal health.
• In November 2024, Polaris Nutritional Lipids announced the commercial launch of Omegavie DHA 800, containing not less than 800 mg/g DHA through high-efficiency molecular distillation technology. Such an extremely concentrated product is dedicated to the pharmaceutical and premium supplement markets requiring extreme potency products.
• In September 2024, KD Pharma Group completed taking over DSM-Firmenich's marine lipids business-unit operations, bringing together its capabilities as a manufacturer of pharmaceutical-grade omega-3s. The deal mirrors consolidation trends across industry and highlights strategic intent focused on highly specialized, high-value applications for omega-3.

The omega-3 fatty acids market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue (USD Billion) & (Kilo Tons) from 2022 to 2035, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Marine-derived omega-3
  • Fish oil
  • Concentrated fish oil
  • Krill oil & phospholipid forms
  • Others
• Algal-derived omega-3
  • Microalgae oil
  • Fermentation-derived EPA & DHA
• Plant-based omega-3 (ala)
  • Flaxseed oil
  • Chia seed oil
  • Others
• Prescription Omega-3 Drugs
• Concentrated & Purified Forms

Market, By Application

• Cardiovascular health
  • Primary prevention products
  • Secondary prevention formulations
  • Blood pressure management
  • Arrhythmia prevention
• General wellness & dietary supplements
  • Daily nutrition
  • Brain health & cognitive function
  • Eye health & vision support
  • Joint health & inflammation
• Functional foods & fortification
  • Dairy product
  • Bakery & confectionery
  • Beverage fortification
  • Meat & poultry
• Infant & maternal nutrition
  • Infant formula applications
  • Prenatal & postnatal supplements
  • Pediatric nutrition products
• Animal feed & aquaculture
  • Aquaculture feed
  • Pet food
  • Livestock feed

Market, By End Use Industry

• Pharmaceutical industry
• Nutraceutical & dietary supplement industry
• Food & beverage industry
• Animal feed industry

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa